Gibbs; Craig
Patent Applications and Registrations
Patent applications and USPTO patent grants for Gibbs; Craig.The latest application filed is for "depletion regimes for engineered t-cell or nk-cell therapy".
- Gibbs; Craig - Palo Alto CA
| Patent | Date |
|---|---|
| Depletion Regimes For Engineered T-cell Or Nk-cell Therapy App 20220288118 - Gibbs; Craig ; et al. | 2022-09-15 |
| Genetically Modified Hspcs Resistant To Ablation Regime App 20220023348 - Gibbs; Craig ; et al. | 2022-01-27 |
| Regimes For Co-administration Of Immunotherapeutic Agents Against C-kit And Cd47 App 20200369767 - Gibbs; Craig ; et al. | 2020-11-26 |
| Anti-inflammatory Phosphonate Compounds App 20090247488 - Cannizzaro; Carina ; et al. | 2009-10-01 |
| Anti-inflammatory phosphonate compounds Grant 7,432,261 - Cannizzaro , et al. October 7, 2 | 2008-10-07 |
| Anti-inflammatory phosphonate compounds App 20060199788 - Cannizzaro; Carina ; et al. | 2006-09-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 